Related Experiment Video
Updated: Jun 18, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
The MDM2-binding region in the transactivation domain of p53 also acts as a Bcl-X(L)-binding motif
Huibin Xu1, Hong Ye, Nur Eliza Osman
1School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore 637551.
Abstract:
While the transcription-dependent mechanism of p53 has been extensively studied, recently the transcription-independent apoptotic activity of p53 has also been described. Bcl-2 and Bcl-X(L) interact with p53 and induce apoptosis. Initially, the p53 DNA-binding domain (p53DBD) was found to bind to Bcl-2 and Bcl-X(L). Later, the p53 N-terminal domain (p53NTD) was reported to be sufficient for inducing the transcription-independent apoptotic activity of p53 and also shown to interact with Bcl-X(L). Here, we further document that the transactivation domain of p53 (p53TAD) in p53NTD alone binds to Bcl-X(L). We demonstrated that the MDM2-binding region (residues S15 to N29, herein referred to as SN15) in p53TAD is the binding site for Bcl-X(L). The binding interface on Bcl-X(L) was identified at the hydrophobic pocket formed by the BH1, BH2, and BH3 domains, which also binds to the Bak/Bad BH3 peptides, suggesting Bcl-X(L) and MDM2 share a common binding motif in p53TAD. Our NMR structural studies have shown that the SN15 peptide undergoes a conformational change upon binding to Bcl-X(L). A Bcl-X(L)/SN15 complex structural model suggests that the SN15 peptide adopts an extended alpha-helical structure to bind to the hydrophobic pocket on the Bcl-X(L), which is similar to the mode of binding between BH3 peptides and Bcl-X(L).
Insights
The p53 transactivation domain (p53TAD) directly binds to Bcl-X(L), a protein involved in apoptosis. This interaction occurs at a specific region (SN15) and involves a conformational change, revealing a shared binding motif with MDM2.
Area of Science:
- Molecular Biology
- Protein-Protein Interactions
- Apoptosis Signaling
Background:
- The tumor suppressor protein p53 has known transcription-dependent and independent roles in apoptosis.
- Bcl-2 and Bcl-X(L) are key regulators of apoptosis that interact with p53.
- Previous studies identified interactions between p53 domains and Bcl-X(L), but the precise binding site and mechanism were unclear.
Purpose of the Study:
- To elucidate the specific binding interaction between the p53 N-terminal domain and Bcl-X(L).
- To identify the precise region within p53 responsible for binding to Bcl-X(L) and inducing transcription-independent apoptosis.
- To characterize the structural basis of the p53-Bcl-X(L) interaction.
Main Methods:
- Nuclear Magnetic Resonance (NMR) spectroscopy to study protein-peptide interactions.
- Identification of binding sites using peptide mapping and structural analysis.
- Structural modeling of the Bcl-X(L)/p53 peptide complex.
Main Results:
- The transactivation domain of p53 (p53TAD), specifically the SN15 region (residues S15-N29), directly binds to Bcl-X(L).
- The binding interface on Bcl-X(L) is a hydrophobic pocket within the BH1, BH2, and BH3 domains, similar to the binding site for Bak/Bad BH3 peptides.
- NMR studies revealed that the SN15 peptide undergoes an alpha-helical conformational change upon binding to Bcl-X(L).
Conclusions:
- The p53 transactivation domain (p53TAD) directly mediates transcription-independent apoptosis by binding to Bcl-X(L).
- The SN15 region of p53TAD binds to a conserved hydrophobic pocket on Bcl-X(L), suggesting a shared binding motif with other Bcl-2 family proteins and MDM2.
- Structural insights into the Bcl-X(L)/SN15 complex provide a mechanistic understanding of p53's role in apoptosis regulation.
Related Concept Videos
Abnormal Proliferation
Master Transcription Regulators
The Intrinsic Apoptotic Pathway
Negative Regulator Molecules
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

